The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

John Navin is a freelance writer for Investopedia. His stock-trading work was profiled in "The Warren Buffetts Next Door: The World's Greatest Investors You've Never Heard Of." Bloomberg/Getty Images ...

The top story of the 2026 stock market is not about how high the next leg of the bull market goes, but which areas of the market no longer carrying it. For the past few years, most of the gains seen ...

Something interesting is happening this year within the S&P 500 — evidenced when a different methodology is applied that gives a fixed weight to each of the 500 companies in the index. The S&P 500 ...

I hate to say it but we told you so. Guest after guest on the Merryn Talks Money podcast has suggested listeners buy gold. Your gold is your insurance, they said. You don’t really want it to go up, as ...

Elysse Bell is a finance and business writer for Investopedia. She writes about small business, personal finance, technology, and more. Erika Rasure is globally-recognized as a leading consumer ...

Investors are facing a risky and highly concentrated U.S. stock market going into 2026, with the "Magnificent 7" representing as much as 35% to 40% of the S&P 500 in recent trading. Nick Ryder, ...

Worried you’re too exposed to AI and Big Tech through your index funds? Equal-weight S&P 500 ETFs are a potential solution, but they have their downsides. Many, or all, of the products featured on ...

MIT Technology Review’s highly subjective take on the latest buzz about AI Separating AI reality from hyped-up fiction isn’t always easy. That’s why we’ve created the AI Hype Index—a simple, ...

Both are low-cost index funds from Vanguard. There are some big potential catalysts favoring value stocks that could happen in 2026. Growth stocks have dramatically outperformed value stocks in recent ...

There are an estimated 7.6 million fewer obese adults today compared with three years ago, new research shows, and injectable weight loss drugs such as Ozempic and Wegovy may be a contributing factor.